These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 6097162)
21. The disposition of 14C-indapamide in man. Klunk LJ; Ringel S; Neiss ES J Clin Pharmacol; 1983; 23(8-9):377-84. PubMed ID: 6630587 [TBL] [Abstract][Full Text] [Related]
22. [Basic studies of cefmenoxime]. Aoyama T Jpn J Antibiot; 1984 Mar; 37(3):290-4. PubMed ID: 6330395 [TBL] [Abstract][Full Text] [Related]
23. [Clinical study on cefmenoxime (CMX) in urology]. Tanaka H; Kato Y; Kakinoki K; Nishio S; Maekawa M; Tsujita M; Nishijima T; Kashihara N; Kono S; Hayahara N Hinyokika Kiyo; 1983 Jan; 29(1):95-103. PubMed ID: 6328956 [TBL] [Abstract][Full Text] [Related]
24. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats. Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071 [TBL] [Abstract][Full Text] [Related]
25. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs. Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers. Blight AR; Henney HR Clin Ther; 2009 Feb; 31(2):328-35. PubMed ID: 19302905 [TBL] [Abstract][Full Text] [Related]
27. [Clinical effect of cefmenoxime on cholecystitis; its clinical efficacy and tissue concentration]. Bekki E; Abe H; Sawada Y; Hashimoto I; Nakamura T; Mikami J; Kasai Y; Nakanishi M Jpn J Antibiot; 1983 Jul; 36(7):1604-14. PubMed ID: 6317907 [TBL] [Abstract][Full Text] [Related]
28. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects. Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of cefmenoxime in patients with impaired renal function and in those undergoing hemodialysis. Konishi K Antimicrob Agents Chemother; 1986 Dec; 30(6):901-5. PubMed ID: 3468882 [TBL] [Abstract][Full Text] [Related]
31. Placental transfer of cefmenoxime in late pregnancy. Bergogne-Bérézin E; Bryskier A; Berthelot G; Ravina JH; Vernant D Chemotherapy; 1985; 31(1):1-5. PubMed ID: 3855746 [TBL] [Abstract][Full Text] [Related]
32. Metabolism and excretion of ropivacaine in humans. Halldin MM; Bredberg E; Angelin B; Arvidsson T; Askemark Y; Elofsson S; Widman M Drug Metab Dispos; 1996 Sep; 24(9):962-8. PubMed ID: 8886605 [TBL] [Abstract][Full Text] [Related]
33. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and metabolism of an intravenously administered penem (Sch 34343) in humans. Lin CC; Lim J; Radwanski E; Kim HK; Marco A; Lapiguera A; DiGiore C; Symchowicz S Antimicrob Agents Chemother; 1987 Jan; 31(1):84-7. PubMed ID: 3566242 [TBL] [Abstract][Full Text] [Related]
35. The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination. Ings RM; Reeves DS; White LO; Bax RP; Bywater MJ; Holt HA J Pharmacokinet Biopharm; 1985 Apr; 13(2):121-42. PubMed ID: 4057054 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of 14C-delmopinol in the healthy male volunteer. Eriksson B; Ottersgård Brorsson AK; Hallström G; Sjödin T; Gunnarsson PO Xenobiotica; 1998 Nov; 28(11):1075-81. PubMed ID: 9879639 [TBL] [Abstract][Full Text] [Related]
37. Determination of cefmenoxime in human body fluids by high-performance liquid chromatography. Borner K; Borner E; Lode H; Peters A Eur J Clin Microbiol; 1983 Feb; 2(1):17-21. PubMed ID: 6301809 [TBL] [Abstract][Full Text] [Related]
38. The absorption, metabolism and excretion of (14C)-AR-L 115 BS in the baboon. Cameron BD; Draffan GH; Dunsire JP; Zimmer A Arzneimittelforschung; 1981; 31(1a):217-20. PubMed ID: 7195225 [TBL] [Abstract][Full Text] [Related]
39. Absorption, metabolism, and excretion of oral ¹⁴C radiolabeled ibrutinib: an open-label, phase I, single-dose study in healthy men. Scheers E; Leclercq L; de Jong J; Bode N; Bockx M; Laenen A; Cuyckens F; Skee D; Murphy J; Sukbuntherng J; Mannens G Drug Metab Dispos; 2015 Feb; 43(2):289-97. PubMed ID: 25488930 [TBL] [Abstract][Full Text] [Related]
40. Study of the diffusion of cefmenoxime into the bronchial secretions. Serieys C; Bergogne-Berezin E; Kafe H; Bryskier A Chemotherapy; 1986; 32(1):1-6. PubMed ID: 3456295 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]